Clin2
NCT07005726Likely a fitEnrolling by invitation

BCG revaccination with DTP3 to reduce infant deaths in Africa

Infant MorbidityInfant MortalityNon-Specific Effects of VaccinesBCG

Treatments studied

Part of Immune system & allergy, Infections clinical trials.

This study tests whether giving another BCG vaccine (the one for tuberculosis) at the same time as the third DTP shot can help reduce serious infections and deaths in babies in Africa. If your baby is healthy and getting their routine DTP3, this could be an option to possibly boost their overall protection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
6,000 people
Ages
3 months to 6 months
Study type
Interventional

Who can take part

  • Your baby is between 14 weeks and 24 weeks old (about 3 to 5.5 months).
  • They got their second DTP shot at least 4 weeks ago and are now due for their third.
  • Your baby is not currently sick enough to need hospital care.
  • They do not have any severe birth defects.
  • They did not have a serious infection in their lymph nodes after their first BCG vaccine.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04899765Recruiting· Phase 4
Measles and BCG shots for moms and toddlers

This trial tests whether giving measles and BCG vaccines to mothers and their children after the child turns 12 months is safe and helpful. It specifically looks at women who are not pregnant and meet several health and study-area requirements.

Bissau, Bissau Codex
NCT04975178Recruiting· Phase 3
Test of a TB vaccine for newborns in sub-Saharan Africa

This Phase 3 study tests whether MTBVAC can safely protect newborn babies from tuberculosis and whether it helps the baby’s immune system learn to fight TB. If you enroll, the goal is to see safety and immune response in real newborn settings in sub-Saharan Africa.

Worcester, Western Cape
NCT07762014Not yet recruiting· Phase 2
A new vaccine for respiratory infections in adults 60 and older

This trial tests a new vaccine designed to help protect older adults from infections that can affect breathing. You might be able to join if you're in generally good health and meet the other requirements listed below.

Athens
NCT06833957Recruiting
Preparing for a maternal GBS vaccine in Africa

This study is preparing for future trials of a vaccine for Group B Strep (GBS) in pregnant women. It includes different parts: watching pregnant women and their babies, surveying GBS infections, and understanding how communities feel about vaccines.

Mariakani, Coast
NCT06947499Recruiting· Phase 2/Phase 3
Testing a 6-in-1 infant vaccine in healthy babies

This study tests a new vaccine that protects babies against 6 diseases (diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib) in just one shot. It’s for healthy infants starting at 6–8 weeks old as their first series of vaccinations.

Dasmariñas, Cavite
NCT06344065Recruiting· Phase 3
New whooping cough combo vaccine for 3-month-old infants

This trial tests a new combination vaccine that protects infants against diphtheria, tetanus, and whooping cough. It is for healthy 3-month-old babies whose parents have not yet given them a similar shot.

Nanning, Guangxi

Hear when a new Infant Morbidity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.